Christopher Wilson, DO
Pain Medicine · Bakersfield, CANPI 1912494717
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.4%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 45.4% of the total.
Across 122 payments — averaging $64.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$2K
- Nevro Corp.$933
- Foundation Fusion Solutions, LLC$507
- Globus Medical$465
- Collegium Pharmaceutical, Inc.$248
- plus $397 from 5 others
What the payments were for
- Grants$2,00025%
- Travel & lodging$1,44318%
- Food & beverage$4,44456%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $3,579 |
| Boston Scientific | 41 | $1,759 |
| Nevro Corp. | 19 | $933 |
| Foundation Fusion Solutions, LLC | 8 | $507 |
| Globus Medical | 17 | $465 |
| Collegium Pharmaceutical, Inc. | 16 | $248 |
| Abbott | 3 | $154 |
| SPR Therapeutics, Inc | 1 | $81 |
| Nalu Medical, Inc. | 2 | $74 |
| Painteq LLC | 2 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$2,000
- INTELLIS ADAPTIVESTIM$1,367
- Senza$439
- Superion Indirect Decompression System$361
- GENERAL PAIN MANAGEMENT$253
- ETERNA$124
How this compares
$7,887 in reported general payments places this provider in the 75th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 39 | $7,930 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 375 | $6,753 |
| MovantikNaloxegol Oxalate | 13 | $5,099 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 114 | $3,308 |
| Pregabalin | 65 | $1,212 |
| Diclofenac Sodium | 34 | $964 |
| Oxycodone Hcl | 39 | $851 |
| Morphine Sulfate ErMorphine Sulfate | 30 | $817 |
| Gabapentin | 97 | $695 |
| Cyclobenzaprine Hcl | 86 | $618 |
| Baclofen | 48 | $479 |
| Tramadol Hcl | 83 | $462 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 19 | $279 |
| Tizanidine Hcl | 44 | $206 |
| Methocarbamol | 21 | $129 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Bakersfield
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
- Einar OttestadStanford$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.